Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Top Benefits of AWS for Educational Institutions
Introduction
A. Overview of AWS in the education sector
In an era where education and technology intersect, Amazon Web Services (AWS) stands as a cornerstone for educational institutions…
|
Top Benefits of AWS for Financial Institutions
Introduction
A. Overview of AWS in the financial sector
In the rapidly evolving landscape of finance, Amazon Web Services (AWS) emerges as a key player, revolutionizing how…
|
Top Benefits of AWS for Healthcare Organizations
Introduction
A. Overview of AWS in the healthcare sector
In an era where technology plays a pivotal role in healthcare, Amazon Web Services (AWS) emerges as a transformative…
|
Top 14 Benefits of AWS for E-commerce Businesses
Introduction
In the ever-evolving landscape of e-commerce, businesses are constantly seeking ways to enhance their operations, improve customer experiences, and stay ahead of the competition. One…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
